SMART pass will prevent inappropriate operation of S-ICD
- PMID: 30805048
- PMCID: PMC6373830
- DOI: 10.1002/joa3.12141
SMART pass will prevent inappropriate operation of S-ICD
Abstract
Background: Compared to screening ECG before implantation of a subcutaneous implantable cardioverter-defibrillator (S-ICD), selectable vectors without T-wave oversensing increase after S-ICD implantation. Newer algorithms have recently become available to reduce T-wave oversensing, such as SMART pass (SP). With this function, more selectable vectors are identified after S-ICD implantation. However, this improvement in eligibility utilizing SP has not yet been well validated. We aimed to clarify S-ICD eligibility before and after S-ICD implantation with and without SP.
Methods: Participants comprised 34 patients implanted with an S-ICD at Okayama University Hospital and its affiliated hospitals between February 2016 and August 2017. A total of 102 S-ICD vectors were assessed for eligibility before and after S-ICD implantation, at rest and during exercise testing. Vector availability was evaluated in the presence and absence of SP after S-ICD implantation.
Results: Subcutaneous implantable cardioverter-defibrillator eligibility was significantly better after implantation even without SP than S-ICD screening before S-ICD implantation, both at rest (before 65.7% vs after 95.1%, P < 0.01) and during exercise (before 59.3% vs after 90.6%, P < 0.01). SP improved S-ICD eligibility during exercise (SP on 97.9% vs off 90.6%, P = 0.03). Multivariate analysis showed the prevalence of S-ICD eligibility increased significantly after S-ICD implantation compared to screening before implantation. SP further increased selectable vectors in multivariate analysis.
Conclusion: Available vectors increased significantly after S-ICD implantation compared to preoperative vectors as assessed by S-ICD screening ECG. T-wave oversensing during exercise has been an unresolved issue for S-ICD, but SP will help prevent inappropriate operation with S-ICD.
Keywords: SMART Pass; T‐wave oversensing; implantable cardioverter‐defibrillator; inappropriate shock; subcutaneous implantable cardioverter‐defibrillator.
Figures
References
-
- Boersma L, Barr C, Knops R, et al. Implant and midterm outcomes of the subcutaneous implantable cardioverter‐defibrillator registry: the EFFORTLESS study. J Am Coll Cardiol. 2017;70(7):830–41. - PubMed
-
- De Maria E, Bonetti L, Patrizi G, et al. Implantation of a completely subcutaneous ICD system: case report of a patient with Brugada syndrome and state of the art. J Interv Card Electrophysiol. 2012;34(1):105–13. - PubMed
-
- Bardy GH, Smith WM, Hood MA, et al. An entirely subcutaneous implantable cardioverter‐defibrillator. N Engl J Med. 2010;363(1):36–44. - PubMed
-
- Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, et al. The entirely subcutaneous implantable cardioverter‐defibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol. 2012;60(19):1933–9. - PubMed
LinkOut - more resources
Full Text Sources
